The actress recalls being misdiagnosed by 8 doctors when she had uterine cancer, and after her hysterectomy, embracing her ...

Amgen Inc. has acquired cancer drug developer Dark Blue Therapeutics Ltd. in a deal worth as much as $840 million, expanding ...

Researchers discovered a promising leukemia drug breakthrough that could help patients overcome treatment resistance, ...

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show ...

Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...

Common diabetes drugs may do more than regulate blood sugar—they could also influence how cancers grow, spread, or slow down.

The FDA designates ARB1002 as an orphan drug, highlighting its potential as a novel treatment for pancreatic cancer amid ...

The startup is developing a medicine that can very specifically degrade cancerous forms of EGFR, the target of several ...

A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors ...

Suleika Jaouad's leukemia experience highlights the importance of mindfulness and support networks in managing the disease.

Some of the top-grossing drugs include Merck's Keytruda, an immunotherapy for multiple cancers with almost $30 billion in ...